-+ 0.00%
-+ 0.00%
-+ 0.00%

US FDA Clears Investigational New Drug Application for Saniona's Depression Treatment

MT Newswires·11/16/2026 04:23:33
Listen to the news
04:23 AM EST, 11/16/2026 (MT Newswires) -- The US Food and Drug Administration approved the investigational new drug application for Saniona's (SANION.ST) major depressive disorder drug SAN2465, according to a Monday release. Following the approval, the biopharmaceutical company plans to launch a phase 1 study to evaluate the drug as a rapid-acting oral treatment for major depressive disorder in healthy volunteers. The trial will comprise both single and multiple ascending doses, with the first participant to be dosed before the end of 2026.